Global Albumin ELISA Test Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. The albumin ELISA (Enzyme-Linked Immunosorbent Assay) test market refers to the market for diagnostic kits used for the measurement of albumin in a patient’s blood sample. Albumin is a protein produced by the liver and is the most abundant protein in the blood. It plays a crucial role in maintaining osmotic pressure, transporting molecules, and regulating pH balance. Abnormal levels of albumin in the blood can indicate a variety of conditions, including liver disease, kidney disease, malnutrition, and inflammation. The market is driven by key factors such as the increasing prevalence of liver diseases and growing demand for point-of-care testing.

According to British Liver Trust, most liver disease patients pass away between the ages of 18 and 65. With 62,000 years of productive life lost each year, liver disease is now the third leading cause of premature mortality in those who are working age. Alcohol, obesity, and viral hepatitis are to blame for 90% of liver disease in the UK, making it avoidable. Each year, about 1000 liver transplants are carried out. At any given time, 350 patients are waiting for liver transplants. Furthermore, the prevalence of liver cancer has been steadily increasing in recent years, with around 840,000 new cases and 780,000 deaths reported worldwide in 2020. However,, the Lack of awareness and the high cost of ELISA test kits stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Albumin ELISA Test Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is currently the largest market for albumin ELISA tests due to the high incidence of liver diseases, high healthcare expenditure, and advanced healthcare infrastructure. Asia-Pacific region is projected to be the fastest-growing region in the albumin ELISA test market. The growth can be attributed to the increasing prevalence of liver diseases, the rising geriatric population, and growing healthcare expenditure in countries such as China, India, and Japan.

Major market player included in this report are:
Wuhan Fine Biotech Co., Ltd.
Padyab Teb Co.
LifeSpan BioSciences, Inc
Thermo Fisher Scientific (China) Co., Ltd.,
MyBiosource, Inc.
Boster Biological Technology
Shanghai Korain Biotech Co., Ltd.
Arbor Assays Inc.
CUSABIO Technology LLC
Elabscience Biotechnology Inc.

Global Albumin ELISA Test Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered – Product Type, End User, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Monoclonal
Polyclonal
Others
By End User:
Hospitals
Diagnostic Laboratories
Research institutions
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa